|
Paresthesia
|
C10.597.751.791.875 |
|
|
Somatosensory Disorders
|
C10.597.751.791 |
|
|
Metabolic Detoxication, Phase II
|
G03.171.450.750 |
|
|
Mycoplasma conjunctivae
|
B03.440.860.580.553.553.220 |
|
|
Patient Handoff
|
E02.760.400.615 |
|
|
Patient Advocacy
|
N03.706.678 |
|
|
cdc25 Phosphatases
|
D12.776.167.100 |
|
|
Cardiorespiratory Fitness
|
I03.450.642.845.054.300 |
|
|
Athletic Performance
|
I03.450.642.845.054 |
|
|
Sperm Maturation
|
G08.686.784.310.760.700 |
|
|
Spermatogenesis
|
G08.686.784.310.760 |
|
|
Patient Discharge
|
E02.760.400.610 |
|
|
Epidural Abscess
|
C01.207.300 |
|
|
Labetalol
|
D02.092.063.291.460 |
|
|
Chlorthalidone
|
D02.478.600.500 |
|
|
Clozapine
|
D03.633.300.240.220 |
|
|
Nikethamide
|
D03.383.725.547.530.500 |
|
|
Electronics, Medical
|
H01.671.293.319 |
|
|
Naphthalimides
|
D02.478.480 |
|
|
Proplast
|
J01.637.051.720.395.616.755 |
|
